The Hospital Authority of Metropolitan Government of Nashville and Davidson County, Tennessee v. Momenta Pharmaceuticals, Inc. et al

  1. March 22, 2017

    Damages Nixed In Generic Blood-Clot Drug Monopoly Suit

    A hospital that indirectly purchased a generic of the blood clot drug Lovenox can request declaratory relief in a proposed class action accusing Momenta Pharmaceuticals Inc. and Sandoz Inc. of conspiring to monopolize the drug's market, but can't seek damages, a Tennessee federal judge said Tuesday.

  2. September 30, 2016

    Momenta, Sandoz Can't Beat Blood Clot Drug Monopoly Suit

    A Tennessee federal magistrate judge on Thursday recommended that a proposed class action accusing Momenta Pharmaceuticals Inc. and Sandoz Inc. of conspiring to monopolize the market for a generic of the blood clot drug Lovenox should stand, as a hospital sufficiently alleged that the companies manipulated the organization that sets quality testing standards.

  3. October 16, 2015

    Momenta, Sandoz Sought Clot Drug Monopoly, Suit Says

    Momenta Pharmaceuticals and Sandoz have been hit with a proposed antitrust class action by a Tennessee hospital alleging they conspired to monopolize the market for a generic version of the blood clot drug Lovenox by manipulating testing standards to ensure a Momenta testing patent would block other competitors.